Wang Y - Search Results

1

Quantitative proteomic study of human prostate cancer cells with different metastatic potentials.

Li Q, Li Y, Wang Y, Cui Z, Gong L, Qu Z, Zhong Y, Zhou J, Zhou Y, Gao Y, Li Y. Li Q, et al. Among authors: wang y. Int J Oncol. 2016 Apr;48(4):1437-46. doi: 10.3892/ijo.2016.3378. Epub 2016 Feb 4. Int J Oncol. 2016. PMID: 26846621

2

KAP1 is overexpressed in hepatocellular carcinoma and its clinical significance.

Wang Y, Jiang J, Li Q, Ma H, Xu Z, Gao Y. Wang Y, et al. Int J Clin Oncol. 2016 Oct;21(5):927-933. doi: 10.1007/s10147-016-0979-8. Epub 2016 Apr 19. Int J Clin Oncol. 2016. PMID: 27095111

3

Identification of microRNAs as novel biomarkers for detecting esophageal squamous cell carcinoma in Asians: a meta-analysis.

Wang Y, Wang Q, Zhang N, Ma H, Gu Y, Tang H, Xu Z, Gao Y. Wang Y, et al. Among authors: wang q. Tumour Biol. 2014 Nov;35(11):11595-604. doi: 10.1007/s13277-014-2350-x. Epub 2014 Aug 19. Tumour Biol. 2014. PMID: 25135426

4

TLR9 signaling promotes tumor progression of human lung cancer cell in vivo.

Ren T, Xu L, Jiao S, Wang Y, Cai Y, Liang Y, Zhou Y, Zhou H, Wen Z. Ren T, et al. Among authors: wang y. Pathol Oncol Res. 2009 Dec;15(4):623-30. doi: 10.1007/s12253-009-9162-0. Epub 2009 Mar 25. Pathol Oncol Res. 2009. PMID: 19319670 Free article.

5

The variation of CD4+CD25+ regulatory T cells in the periphery blood and tumor microenvironment of non-small cell lung cancer patients and the downregulation effects induced by CpG ODN.

Wang YY, He XY, Cai YY, Wang ZJ, Lu SH. Wang YY, et al. Target Oncol. 2011 Sep;6(3):147-54. doi: 10.1007/s11523-011-0182-9. Epub 2011 May 25. Target Oncol. 2011. PMID: 21611754 Clinical Trial.

6

Role of ZIC1 methylation in hepatocellular carcinoma and its clinical significance.

Wang YY, Jiang JX, Ma H, Han J, Sun ZY, Liu ZM, Xu ZG. Wang YY, et al. Tumour Biol. 2014 Aug;35(8):7429-33. doi: 10.1007/s13277-014-1971-4. Epub 2014 Apr 30. Tumour Biol. 2014. PMID: 24782033

7

Detection of microRNA-21 expression as a potential screening biomarker for colorectal cancer: a meta-analysis.

Jiang JX, Zhang N, Liu ZM, Wang YY. Jiang JX, et al. Asian Pac J Cancer Prev. 2014;15(18):7583-8. doi: 10.7314/apjcp.2014.15.18.7583. Asian Pac J Cancer Prev. 2014. PMID: 25292032 Free article.

8

E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p/COL6A3 pathway.

Yu J, Zhang B, Zhang H, Qi Y, Wang Y, Wang W, Wang Y, Wang Y. Yu J, et al. Among authors: wang w, wang y. Biochem Biophys Res Commun. 2019 Apr 30;512(2):150-155. doi: 10.1016/j.bbrc.2019.03.054. Epub 2019 Mar 13. Biochem Biophys Res Commun. 2019. PMID: 30876691

9

MicroRNA let-7a inhibits the proliferation and invasion of nonsmall cell lung cancer cell line 95D by regulating K-Ras and HMGA2 gene expression.

Wang YY, Ren T, Cai YY, He XY. Wang YY, et al. Cancer Biother Radiopharm. 2013 Mar;28(2):131-7. doi: 10.1089/cbr.2012.1307. Epub 2012 Nov 7. Cancer Biother Radiopharm. 2013. PMID: 23134218

10

Long non-coding RNA LOXL1-AS1 acts as a ceRNA for miR-324-3p to contribute to cholangiocarcinoma progression via modulation of ATP-binding cassette transporter A1.

Zhang B, Zhou M, Zou L, Miao J, Wang Y, Li Y, Lu S, Yu J. Zhang B, et al. Among authors: wang y. Biochem Biophys Res Commun. 2019 Jun 11;513(4):827-833. doi: 10.1016/j.bbrc.2019.04.089. Epub 2019 Apr 16. Biochem Biophys Res Commun. 2019. PMID: 31003776

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299,544 results

Search Page

Filters